4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-24-003154
President & CEO sold 12,500 shares at $79.57 ($994,625)
- President & CEO acquired 12,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Blum Robert I · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-31 | Exercise or conversion : show line 1 in the form 10b5-1 | +12,500 | $6.67 | $83,375 | 454,297 | D |
| 2024-01-31 | Sale : show line 2 in the form 10b5-1 | −12,500 | $79.57 | $994,625 | 441,797 | D |
| Open-market sales · 12,500 sh · avg $79.57 · $994,625 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-01-31 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) | −12,500 | 130,994 | D |
Loading xslF345X05/form4.xml…